P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia
Background: It has been consistently reported that the deficiency of the adenosine triphosphate (ATP) sensitive purinergic receptor P2X7 (P2X7R) ameliorates symptoms in animal models of brain diseases.Objective: This study aimed to investigate the role of P2X7R in rodent models of acute and subchron...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2020.566251/full |
id |
doaj-eff053934d3d4d02970cad39ec5d8bd7 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Stefano Calovi Stefano Calovi Paula Mut-Arbona Paula Mut-Arbona Pál Tod András Iring Annette Nicke Susana Mato Susana Mato Susana Mato Susana Mato E. Sylvester Vizi Jan Tønnesen Jan Tønnesen Beata Sperlagh |
spellingShingle |
Stefano Calovi Stefano Calovi Paula Mut-Arbona Paula Mut-Arbona Pál Tod András Iring Annette Nicke Susana Mato Susana Mato Susana Mato Susana Mato E. Sylvester Vizi Jan Tønnesen Jan Tønnesen Beata Sperlagh P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia Frontiers in Molecular Neuroscience P2X7 receptor schizophrenia microglia phencyclidine prefrontal cortex |
author_facet |
Stefano Calovi Stefano Calovi Paula Mut-Arbona Paula Mut-Arbona Pál Tod András Iring Annette Nicke Susana Mato Susana Mato Susana Mato Susana Mato E. Sylvester Vizi Jan Tønnesen Jan Tønnesen Beata Sperlagh |
author_sort |
Stefano Calovi |
title |
P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia |
title_short |
P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia |
title_full |
P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia |
title_fullStr |
P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia |
title_full_unstemmed |
P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia |
title_sort |
p2x7 receptor-dependent layer-specific changes in neuron-microglia reactivity in the prefrontal cortex of a phencyclidine induced mouse model of schizophrenia |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Molecular Neuroscience |
issn |
1662-5099 |
publishDate |
2020-11-01 |
description |
Background: It has been consistently reported that the deficiency of the adenosine triphosphate (ATP) sensitive purinergic receptor P2X7 (P2X7R) ameliorates symptoms in animal models of brain diseases.Objective: This study aimed to investigate the role of P2X7R in rodent models of acute and subchronic schizophrenia based on phencyclidine (PCP) delivery in animals lacking or overexpressing P2X7R, and to identify the underlying mechanisms involved.Methods: The psychotomimetic effects of acute i.p. PCP administration in C57Bl/6J wild-type, P2X7R knockout (P2rx7−/−) and overexpressing (P2X7-EGFP) young adult mice were quantified. The medial prefrontal cortex (mPFC) of P2rx7−/− and heterozygous P2X7-EGFP acutely treated animals was characterized through immunohistochemical staining. The prefrontal cortices of young adult P2rx7−/− and P2rx7tg/+ mice were examined with tritiated dopamine release experiments and the functional properties of the mPFC pyramidal neurons in layer V from P2rx7−/− mice were assessed by patch-clamp recordings. P2rx7−/− animals were subjected to a 7 days subchronic systemic PCP treatment. The animals working memory performance and PFC cytokine levels were assessed.Results: Our data strengthen the hypothesis that P2X7R modulates schizophrenia-like positive and cognitive symptoms in NMDA receptor antagonist models in a receptor expression level-dependent manner. P2X7R expression leads to higher medial PFC susceptibility to PCP-induced circuit hyperactivity. The mPFC of P2X7R knockout animals displayed distinct alterations in the neuronal activation pattern, microglial organization, specifically around hyperactive neurons, and were associated with lower intrinsic excitability of mPFC neurons.Conclusions: P2X7R expression exacerbated PCP-related effects in C57Bl/6J mice. Our findings suggest a pleiotropic role of P2X7R in the mPFC, consistent with the observed behavioral phenotype, regulating basal dopamine concentration, layer-specific neuronal activation, intrinsic excitability of neurons in the mPFC, and the interaction of microglia with hyperactive neurons. Direct measurements of P2X7R activity concerning microglial ramifications and dynamics could help to further elucidate the molecular mechanisms involved. |
topic |
P2X7 receptor schizophrenia microglia phencyclidine prefrontal cortex |
url |
https://www.frontiersin.org/articles/10.3389/fnmol.2020.566251/full |
work_keys_str_mv |
AT stefanocalovi p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT stefanocalovi p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT paulamutarbona p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT paulamutarbona p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT paltod p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT andrasiring p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT annettenicke p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT susanamato p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT susanamato p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT susanamato p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT susanamato p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT esylvestervizi p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT jantønnesen p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT jantønnesen p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia AT beatasperlagh p2x7receptordependentlayerspecificchangesinneuronmicrogliareactivityintheprefrontalcortexofaphencyclidineinducedmousemodelofschizophrenia |
_version_ |
1724455363014557696 |
spelling |
doaj-eff053934d3d4d02970cad39ec5d8bd72020-11-25T03:59:07ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992020-11-011310.3389/fnmol.2020.566251566251P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of SchizophreniaStefano Calovi0Stefano Calovi1Paula Mut-Arbona2Paula Mut-Arbona3Pál Tod4András Iring5Annette Nicke6Susana Mato7Susana Mato8Susana Mato9Susana Mato10E. Sylvester Vizi11Jan Tønnesen12Jan Tønnesen13Beata Sperlagh14Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, HungaryJános Szentágothai Doctoral School, Semmelweis University, Budapest, HungaryLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, HungaryJános Szentágothai Doctoral School, Semmelweis University, Budapest, HungaryLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, HungaryLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, HungaryWalther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, LMU Munich, Munich, GermanyAchucarro Basque Center for Neuroscience, Leioa, SpainDepartment of Neuroscience, University of the Basque Country (UPV/EHU), Leioa, SpainCentro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, SpainBiocruces Bizkaia, Barakaldo, SpainLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, HungaryAchucarro Basque Center for Neuroscience, Leioa, SpainDepartment of Neuroscience, University of the Basque Country (UPV/EHU), Leioa, SpainLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, HungaryBackground: It has been consistently reported that the deficiency of the adenosine triphosphate (ATP) sensitive purinergic receptor P2X7 (P2X7R) ameliorates symptoms in animal models of brain diseases.Objective: This study aimed to investigate the role of P2X7R in rodent models of acute and subchronic schizophrenia based on phencyclidine (PCP) delivery in animals lacking or overexpressing P2X7R, and to identify the underlying mechanisms involved.Methods: The psychotomimetic effects of acute i.p. PCP administration in C57Bl/6J wild-type, P2X7R knockout (P2rx7−/−) and overexpressing (P2X7-EGFP) young adult mice were quantified. The medial prefrontal cortex (mPFC) of P2rx7−/− and heterozygous P2X7-EGFP acutely treated animals was characterized through immunohistochemical staining. The prefrontal cortices of young adult P2rx7−/− and P2rx7tg/+ mice were examined with tritiated dopamine release experiments and the functional properties of the mPFC pyramidal neurons in layer V from P2rx7−/− mice were assessed by patch-clamp recordings. P2rx7−/− animals were subjected to a 7 days subchronic systemic PCP treatment. The animals working memory performance and PFC cytokine levels were assessed.Results: Our data strengthen the hypothesis that P2X7R modulates schizophrenia-like positive and cognitive symptoms in NMDA receptor antagonist models in a receptor expression level-dependent manner. P2X7R expression leads to higher medial PFC susceptibility to PCP-induced circuit hyperactivity. The mPFC of P2X7R knockout animals displayed distinct alterations in the neuronal activation pattern, microglial organization, specifically around hyperactive neurons, and were associated with lower intrinsic excitability of mPFC neurons.Conclusions: P2X7R expression exacerbated PCP-related effects in C57Bl/6J mice. Our findings suggest a pleiotropic role of P2X7R in the mPFC, consistent with the observed behavioral phenotype, regulating basal dopamine concentration, layer-specific neuronal activation, intrinsic excitability of neurons in the mPFC, and the interaction of microglia with hyperactive neurons. Direct measurements of P2X7R activity concerning microglial ramifications and dynamics could help to further elucidate the molecular mechanisms involved.https://www.frontiersin.org/articles/10.3389/fnmol.2020.566251/fullP2X7 receptorschizophreniamicrogliaphencyclidineprefrontal cortex |